Canada vs Rwanda: Treatment success rate for patients treated for MDR-TB
Canada
87.0%
in 2014
Rwanda
87.0%
in 2022
Canada rank
27th
Rwanda rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Canada
- Rwanda
How they compare
Canada currently reports 87.0% against 87.0% in Rwanda, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2006 it was Rwanda ahead.
Canada ranks 27th and Rwanda ranks 27th of 163 countries.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.2% | 88.0% | 26.8% | Rwanda |
| 2010s | 79.4% | 89.4% | 10.0% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Canada or Rwanda?
- Canada, at 87.0% against 87.0% in Rwanda as of 2014.
- What is the difference in treatment success rate for patients treated for mdr-tb between Canada and Rwanda?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Rwanda?
- 9 years are reported by both, from 2006 to 2014.
- How do Canada and Rwanda rank globally for treatment success rate for patients treated for mdr-tb?
- Canada ranks 27th and Rwanda ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.